In This Article:
As global markets navigate through heightened geopolitical tensions and economic uncertainties, the Swedish market remains a focal point for investors seeking growth opportunities. In this environment, companies with high insider ownership often attract attention due to their potential for aligned interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership In Sweden
| Name | Insider Ownership | Earnings Growth |
| CTT Systems (OM:CTT) | 16.9% | 24.8% |
| Truecaller (OM:TRUE B) | 29.6% | 21.6% |
| Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
| Biovica International (OM:BIOVIC B) | 18.3% | 78.5% |
| BioArctic (OM:BIOA B) | 34% | 98.4% |
| KebNi (OM:KEBNI B) | 36.3% | 86.1% |
| Yubico (OM:YUBICO) | 37.5% | 42.3% |
| InCoax Networks (OM:INCOAX) | 19.5% | 115.5% |
| C-Rad (OM:CRAD B) | 16.1% | 33.9% |
| OrganoClick (OM:ORGC) | 23.1% | 109.0% |
Below we spotlight a couple of our favorites from our exclusive screener.
Lime Technologies
Simply Wall St Growth Rating: ★★★★★☆
Overview: Lime Technologies AB (publ) offers SaaS-based CRM solutions in the Nordic region and has a market cap of SEK4.59 billion.
Operations: The company generates revenue from selling and implementing CRM software systems, totaling SEK631.84 million.
Insider Ownership: 10.7%
Earnings Growth Forecast: 22.4% p.a.
Lime Technologies shows strong growth potential, with earnings projected to increase by 22.4% annually, outpacing the Swedish market's 15.2%. Despite high debt levels, it trades at a discount of 26.4% below its fair value estimate and boasts a robust forecasted return on equity of 38.6%. Recent financials reveal steady revenue growth from SEK 290.38 million to SEK 344.14 million in six months, alongside consistent dividend payouts totaling SEK 46,492 million for 2024.
Medicover
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK27.72 billion.
Operations: The company generates revenue from Diagnostic Services amounting to €610 million and Healthcare Services totaling €1.32 billion.
Insider Ownership: 11.1%
Earnings Growth Forecast: 38.6% p.a.
Medicover's earnings are forecast to grow significantly at 38.6% annually, surpassing the Swedish market's average of 15.2%. Despite trading at a substantial discount of 47.1% below its estimated fair value, insider activity shows more buying than selling recently. The company anticipates organic revenue over €2.2 billion by year-end 2025, though interest payments remain inadequately covered by earnings. Recent leadership changes include Anand Patel as CFO, bringing extensive retail finance experience to Medicover's executive team.